HeartSciences (HSCS) Free Cash Flow Growth (3y) (2024 - 2026)
HeartSciences (HSCS) Free Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -20.37% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 19.32% |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - | -12.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -12.39% |
| Oct 31, 2025 | -29.29% |
| Jul 31, 2025 | -2.40% |
| Apr 30, 2025 | -10.08% |
| Jan 31, 2025 | -18.80% |
| Oct 31, 2024 | -41.66% |
| Jul 31, 2024 | -41.17% |